The American College of Chest Physicians recently released a new clinical guideline on biologic management in severe asthma.
Biologics targeting inflammatory pathways have revolutionized asthma treatment. However, adherence and persistence remain a ...
Please provide your email address to receive an email when new articles are posted on . A 50% or greater reduction in exacerbation rate was one of the four criteria for response. Criteria also ...
Please provide your email address to receive an email when new articles are posted on . Researchers captured how caregivers view biologics for pediatric asthma via survey. When presented with the ...
Eosinophil cells Research presented at ACAAI 2021 evaluated the efficacy of different biologic therapies in controlling asthma exacerbations in patients with varying BECs. The following article ...
CLEVELAND, Ohio. (KFSN) -- About 25 million Americans suffer from asthma. For people with severe forms of the disease, every single breath can be a struggle. Now, there's new hope for these patients A ...
There's a treatment on the rise in the medical industry. It's called Biologics, and it's helping treat severe eczema and asthma. Christi Vandegrift makes cleaning her front porch look easy, but it ...
In CHRONICLE, researchers examined associations between exacerbations and initiation of biologic therapy in patients with uncontrolled severe asthma. The following article features coverage from the ...
Biologic therapies for asthma and CRSwNP may reduce ear-related symptoms, including otitis media, ear fullness, pain, and dizziness. A retrospective analysis showed significant improvements in ...
The latest advances in asthma care combine revolutionary biologics, individualized immunotherapy, and targeted treatments that address specific triggers, ditching the “one-size-fits-all” approach. The ...
Asthma causes inflammation and narrowing of the airways, making it harder to breathe. Symptoms may include wheezing, coughing, chest tightness, and shortness of breath. These symptoms can vary in ...
Asthma and COPD Drugs Market is expected to reach US$ 82.2 Billion by 2036, driven by Advancements in Drug Discovery and ...